California Cancer Reporting System Standards, Volume III

Eureka

IF 1025: CS SSF 12, SSF 13, Prostate Schema

Edit Sets

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

Fields

Behavior Code ICD-O-3 [NAACCR #523]

CS Site-Specific Factor 12 [NAACCR #2866]

CS Site-Specific Factor 13 [NAACCR #2867]

CS Site-Specific Factor 25 [NAACCR #2879]

Histologic Type ICD-O-3 [NAACCR #522]

Primary Site [NAACCR #400]

Tables

N/A

Messages

IF1025: Prostate schema: CS Site-Specific Factor 12 and CS Site-Specific Factor 13 conflict

Specification

Purpose: This edit verifies that, for cases coded using the Prostate Schema,  CS Site-Specific Factor12 (number of cores positive) and CS Site-Specific Factor13 (number of cores examined) are coded consistently.

If CS schema is Prostate:

1. If CS Site Specific Factor13 (number of cores examined) = 001-101, then CS Site Specific Factor12 (number of cores positive) must = 991 (biopsy cores positive, number unknown) or be less than or equal to CS Site Specific Factor13 or equal to 999.

2. If CS Site Specific Factor13 = 991 (biopsy cores examined, number unknown), then CS Site Specific Factor12 must = 000-101, 991 or 999.

3. If CS Site Specific Factor13 = 998 (no needle core biopsy performed), then CS Site Specific Factor12 must = 998 (no needle core biopsy performed).

4. If CS Site Specific Factor12 = 998, then CS Site Specific Factor13 must = 998.

This edit is skipped if any of the following conditions are true:

1. CS Site-Specific Factor12 is blank or 988

2. CS Site-Specific Factor13 is blank or 988

3. Schema is invalid

This edit first determines the CS schema by doing a function call to the CS Dynamic Link Library (dll).  The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.

Historical Changes